4,6-pyr-beta-D-GlcpNAc-(1->3)-alpha-D-Galp-(1->4)-beta-L-Rhap

Term ID

CHEBI:61738

Synonyms

2-acetamido-4,6-O-[(1S)-1-carboxyethylidene]-2-deoxy-beta-D-glucopyranosyl-(1->3)-alpha-D-galactopyranosyl-(1->4)-6-deoxy-beta-L-mannopyranose
2-acetamido-4,6-O-[(1S)-1-carboxyethylidene]-2-deoxy-beta-D-glucopyranosyl-(1->3)-alpha-D-galactopyranosyl-(1->4)-beta-L-rhamnopyranose
4,6-O-[(1S)-1-carboxyethylidene]-N-acetyl-beta-D-glucosaminyl-(1->3)-alpha-D-galactosyl-(1->4)-beta-L-rhamnose
4,6-pyr-beta-D-GlcNAc-(1->3)-alpha-D-Gal-(1->4)-beta-L-Rha

Definition

An amino trisaccharide consisting of beta-L-rhamnose at the reducing end having a 4,6-O-[(1S)-1-carboxyethylidene]-N-acetyl-beta-D-glucosaminyl-(1->3)-alpha-D-galactosyl group attached at the 4-position.

References

PMID:87460

Ontology

ChEBI ( EBI )

Relationships

is a type of: amino trisaccharide carbohydrate derivative cyclic ketal

amino trisaccharide carbohydrate derivative cyclic ketal Show first 5 Terms

Phenotype

Phenotype resulting from 4,6-pyr-beta-D-GlcpNAc-(1->3)-alpha-D-Galp-(1->4)-beta-L-Rhap

Phenotype where environments contain 4,6-pyr-beta-D-GlcpNAc-(1->3)-alpha-D-Galp-(1->4)-beta-L-Rhap

Phenotype modified by environments containing 4,6-pyr-beta-D-GlcpNAc-(1->3)-alpha-D-Galp-(1->4)-beta-L-Rhap

Human Disease Model